AXIM Biotechnologies' Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity

Stock Information for Axim Biotechnologies Inc

Loading

Please wait while we load your information from QuoteMedia.